Literature DB >> 12832993

Carotid intervention prior to or during coronary artery bypass grafting. When is it necessary?

D F Bandyk1, M R Back, B L Johnson, M L Shames.   

Abstract

Management of patients with advanced atherosclerosis involving the extra-cranial carotid and coronary arteries should be individualized based on symptoms and disease severity. A liberal policy to identify high-grade carotid stenosis using duplex ultrasound testing prior to coronary revascularization is recommended. Carotid intervention is efficacious for stroke reduction in patients with severe (>70% diameter reduction), bilateral internal carotid artery disease, especially if testing indicates abnormal cerebral perfusion via the circle of Willis. The morbidity of a combined carotid-coronary revascularization procedure should be less than 5%, but higher stroke and death rates can be expected in urgent cases with recent hemispheric symptoms. Patients with symptomatic >50% internal carotid artery stenosis should be considered for carotid endarterectomy at the time of coronary revascularization. Carotid angioplasty with cerebral protection is also an appropriate option in "high-risk" cardiac patients, especially in vascular centers with expertise and experience in performing this procedure. A policy of carotid endarterectomy prior to coronary bypass grafting is justified only in patients with stable coronary disease, good ejection fraction, and is best-performed using regional anesthesia.

Entities:  

Mesh:

Year:  2003        PMID: 12832993

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  1 in total

1.  Peripheral vascular disease endovascular management in patients scheduled for cardiac surgery: a clinical-angiographic approach.

Authors:  Gianluca Rigatelli; Paolo Cardaioli; Massimo Giordan; Loris Roncon; Giuseppe Faggian; Giorgio Rigatelli; Pietro Zonzin
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-09       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.